Your browser doesn't support javascript.
loading
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.
Hoeper, Marius M; Simonneau, Gérald; Corris, Paul A; Ghofrani, Hossein-Ardeschir; Klinger, James R; Langleben, David; Naeije, Robert; Jansa, Pavel; Rosenkranz, Stephan; Scelsi, Laura; Grünig, Ekkehard; Vizza, Carmine Dario; Chang, MiKyung; Colorado, Pablo; Meier, Christian; Busse, Dennis; Benza, Raymond L.
Afiliação
  • Hoeper MM; Clinic for Respiratory Medicine, Hannover Medical School, member of the German Centre for Lung Research (DZL), Hannover, Germany Hoeper.Marius@mh-hannover.de.
  • Simonneau G; Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Bicêtre, Université Paris-Sud, Laboratoire d'Excellence en Recherche sur le Médicament et Innovation Thérapeutique, and INSERM Unité 999, Le Kremlin-Bicêtre, France.
  • Corris PA; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Ghofrani HA; University of Giessen and Marburg Lung Centre, member of the German Centre for Lung Research (DZL), Giessen, Germany.
  • Klinger JR; Dept of Medicine, Imperial College London, London, UK.
  • Langleben D; Division of Pulmonary, Sleep, and Critical Care Medicine, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
  • Naeije R; Centre for Pulmonary Vascular Disease and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Jansa P; Dept of Cardiology, Erasme University Hospital, Brussels, Belgium.
  • Rosenkranz S; Clinical Dept of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Dept, Charles University, Prague, Czech Republic.
  • Scelsi L; Clinic III for Internal Medicine (Cardiology), and Centre for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Grünig E; Cologne Cardiovascular Research Centre (CCRC), University of Cologne, Cologne, Germany.
  • Vizza CD; Division of Cardiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy.
  • Chang M; Centre for Pulmonary Hypertension, Thorax Clinic at the University Hospital, Heidelberg, Germany.
  • Colorado P; Pulmonary Hypertension Unit, Dept of Cardiovascular and Respiratory Disease, 'La Sapienza' University of Rome, Rome, Italy.
  • Meier C; Global Medical Affairs, Bayer Pharma AG, Berlin, Germany.
  • Busse D; Global Clinical Development, Bayer HealthCare Pharmaceuticals, Barcelona, Spain.
  • Benza RL; Global Medical Affairs, Bayer Pharma AG, Berlin, Germany.
Eur Respir J ; 50(3)2017 09.
Article em En | MEDLINE | ID: mdl-28889107
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Hipertensão Pulmonar / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Hipertensão Pulmonar / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article